rockits
Member
- Messages
- 9,172
There’s a lot of hype around all these drug co’s at the moment, seems just announcing that you are developing a vaccine is enough to send stock leaping, even if the product is a long way off.
I’d tend to watch them and see if any momentum builds- I encashed ABBV and Gilead after a decent run and haven’t got back in.
Only one I’m in is NCYT for the long haul as testing accuracy seems to be key at the moment.
Read a good little post on LSE share chat for NCYT tonight. Worth reading. Saying about their Antigen and Antibody tests. One is 100% but other is 50% but moving forward.
Posters name is Quickdraw18 I think.
Looks like they might have got approval to supply Africa now as well.
I'm still holding these for a bit. Not sure whether to add a bit more.